The EMA and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) have launched the E-Register of Studies.
The register will increase the availability of information on the utilisation, safety and effectiveness of medicines used in clinical practice.
The database is a publicly accessible resource for the consultation of pharmaco-epidemiological and pharmacovigilance studies conducted by academic centres and other research organisations.
The ENCePP, which is led by the EMA, is intended to enhance the way medicines are monitored once they have been approved by facilitating the conduct of high quality, multi-centre, independent, post-authorisation studies.
The neutral register with include both positive and negative study results. It will promote the exchange of information and hopes to increase collaboration within the scientific community and prevent organisations duplicating research.
The launch of the database is the latest milestone achieved by ENCePP. Recently it adopted the ENCePP Code of Conduct, and also launched the public consultation of the Guide on Methodological Standards for pharmacoepidemiological studies and an inventory of resources.
The register can be found here.